Cue Historical Income Statement

HLTH Stock

USD 0.44 0.01 2.22%

Historical analysis of Cue Health income statement accounts such as Selling General Administrative of 58.1 M or Selling And Marketing Expenses of 33.2 M can show how well Cue Health performed in making a profits. Evaluating Cue Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cue Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Cue Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cue Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Cue Income Statement Analysis

Cue Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cue Health shareholders. The income statement also shows Cue investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cue Health Income Statement Chart

As of now, Cue Health's Cost Of Revenue is increasing as compared to previous years.

Selling General Administrative Selling And Marketing Expenses Total Revenue Other Operating Expenses Net Income From Continuing Ops

Total Revenue

Total revenue comprises all receipts Cue Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cue Health. It is also known as Cue Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Cue Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cue Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

As of now, Cue Health's Cost Of Revenue is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Interest Expense	9.8M	645K	1.2M	1.1M
Depreciation And Amortization	32.5M	2.5M	56.3M	59.1M

Interest Expense Depreciation And Amortization

Cue Health income statement Correlations

	Net Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Income	Non Operating Income Net Other
Net Interest Income		-0.38	-1.0	-0.57	-0.26	-0.79	-0.88	-0.46	-0.29	-0.3	-0.29	-0.08	-0.4	-0.6	-0.28	-0.42	-0.27	-0.19	-0.21	-0.94	0.01	0.01
Depreciation And Amortization	-0.38		0.39	0.57	0.38	0.24	0.05	0.52	-0.65	-0.63	-0.65	0.55	-0.54	0.46	0.54	0.72	-0.7	-0.83	-0.74	0.45	0.76	-0.88
Interest Expense	-1.0	0.39		0.58	0.27	0.79	0.87	0.47	0.28	0.29	0.28	0.09	0.39	0.61	0.29	0.43	0.27	0.19	0.21	0.94	0.0	-0.02
Selling General Administrative	-0.57	0.57	0.58		0.92	0.85	0.65	0.99	-0.5	-0.51	-0.5	0.83	-0.45	0.97	0.94	0.93	-0.47	-0.31	-0.5	0.33	0.66	-0.4
Selling And Marketing Expenses	-0.26	0.38	0.27	0.92		0.74	0.48	0.97	-0.6	-0.62	-0.6	0.91	-0.6	0.92	0.97	0.87	-0.55	-0.29	-0.56	-0.03	0.68	-0.32
Total Revenue	-0.79	0.24	0.79	0.85	0.74		0.94	0.82	0.01	0.0	0.01	0.5	0.06	0.91	0.69	0.67	0.05	0.2	0.01	0.54	0.22	0.04
Gross Profit	-0.88	0.05	0.87	0.65	0.48	0.94		0.58	0.34	0.32	0.34	0.19	0.39	0.73	0.41	0.41	0.36	0.45	0.33	0.67	-0.09	0.27
Other Operating Expenses	-0.46	0.52	0.47	0.99	0.97	0.82	0.58		-0.56	-0.57	-0.56	0.89	-0.52	0.97	0.97	0.94	-0.52	-0.32	-0.55	0.21	0.7	-0.38
Operating Income	-0.29	-0.65	0.28	-0.5	-0.6	0.01	0.34	-0.56		1.0	1.0	-0.83	0.99	-0.38	-0.71	-0.69	1.0	0.89	0.99	0.34	-0.93	0.79
Net Income From Continuing Ops	-0.3	-0.63	0.29	-0.51	-0.62	0.0	0.32	-0.57	1.0		1.0	-0.84	0.99	-0.39	-0.72	-0.69	0.99	0.87	0.98	0.37	-0.92	0.76
Ebit	-0.29	-0.65	0.28	-0.5	-0.6	0.01	0.34	-0.56	1.0	1.0		-0.83	0.99	-0.38	-0.71	-0.69	1.0	0.89	0.99	0.34	-0.93	0.79
Research Development	-0.08	0.55	0.09	0.83	0.91	0.5	0.19	0.89	-0.83	-0.84	-0.83		-0.81	0.76	0.97	0.93	-0.79	-0.59	-0.8	-0.12	0.91	-0.49
Ebitda	-0.4	-0.54	0.39	-0.45	-0.6	0.06	0.39	-0.52	0.99	0.99	0.99	-0.81		-0.33	-0.68	-0.63	0.98	0.84	0.96	0.47	-0.88	0.71
Cost Of Revenue	-0.6	0.46	0.61	0.97	0.92	0.91	0.73	0.97	-0.38	-0.39	-0.38	0.76	-0.33		0.9	0.86	-0.34	-0.16	-0.37	0.35	0.54	-0.3
Total Operating Expenses	-0.28	0.54	0.29	0.94	0.97	0.69	0.41	0.97	-0.71	-0.72	-0.71	0.97	-0.68	0.9		0.95	-0.67	-0.45	-0.68	0.04	0.81	-0.44
Reconciled Depreciation	-0.42	0.72	0.43	0.93	0.87	0.67	0.41	0.94	-0.69	-0.69	-0.69	0.93	-0.63	0.86	0.95		-0.68	-0.56	-0.71	0.25	0.87	-0.53
Income Before Tax	-0.27	-0.7	0.27	-0.47	-0.55	0.05	0.36	-0.52	1.0	0.99	1.0	-0.79	0.98	-0.34	-0.67	-0.68		0.93	1.0	0.3	-0.93	0.82
Total Other Income Expense Net	-0.19	-0.83	0.19	-0.31	-0.29	0.2	0.45	-0.32	0.89	0.87	0.89	-0.59	0.84	-0.16	-0.45	-0.56	0.93		0.94	0.1	-0.85	0.91
Net Income	-0.21	-0.74	0.21	-0.5	-0.56	0.01	0.33	-0.55	0.99	0.98	0.99	-0.8	0.96	-0.37	-0.68	-0.71	1.0	0.94		0.24	-0.94	0.85
Income Tax Expense	-0.94	0.45	0.94	0.33	-0.03	0.54	0.67	0.21	0.34	0.37	0.34	-0.12	0.47	0.35	0.04	0.25	0.3	0.1	0.24		-0.08	-0.09
Interest Income	0.01	0.76	0.0	0.66	0.68	0.22	-0.09	0.7	-0.93	-0.92	-0.93	0.91	-0.88	0.54	0.81	0.87	-0.93	-0.85	-0.94	-0.08		-0.71
Non Operating Income Net Other	0.01	-0.88	-0.02	-0.4	-0.32	0.04	0.27	-0.38	0.79	0.76	0.79	-0.49	0.71	-0.3	-0.44	-0.53	0.82	0.91	0.85	-0.09	-0.71

Click cells to compare fundamentals

Cue Health Account Relationship Matchups

Currently Active Assets on Macroaxis

NXPI	NXP Semiconductors NV
MSFT	Microsoft
DIS	Walt Disney
XLK	Technology Select Sector
BOTZ	Global X Robotics

Other Information on Investing in Cue Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cue Historical Income Statement

About Cue Income Statement Analysis

Cue Health Income Statement Chart

Total Revenue

Other Operating Expenses

Cue Health income statement Correlations

Cue Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

Other Information on Investing in Cue Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tax Provision	Net Interest Income
Depreciation And Amortization	Interest Expense
Selling General Administrative	Selling And Marketing Expenses
Total Revenue	Gross Profit
Other Operating Expenses	Operating Income
Net Income From Continuing Ops	Ebit
Research Development	Ebitda
Cost Of Revenue	Total Operating Expenses
Reconciled Depreciation	Income Before Tax
Total Other Income Expense Net	Net Income Applicable To Common Shares
Net Income	Income Tax Expense
Interest Income	Non Operating Income Net Other

Net Income From Continuing Ops	+ 1.0	Operating Income
Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Ebit	+ 1.0	Net Income From Continuing Ops
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax

Interest Expense	- 1.0	Net Interest Income
Interest Income	- 0.94	Net Income
Income Tax Expense	- 0.94	Net Interest Income
Interest Income	- 0.93	Income Before Tax
Interest Income	- 0.93	Ebit
Interest Income	- 0.93	Operating Income